Related Experiment Video
Updated: Aug 27, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Primate hemorrhagic fever-causing arteriviruses are poised for spillover to humans
Cody J Warren1, Shuiqing Yu2, Douglas K Peters1
1BioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80303, USA.
Abstract:
Simian arteriviruses are endemic in some African primates and can cause fatal hemorrhagic fevers when they cross into primate hosts of new species. We find that CD163 acts as an intracellular receptor for simian hemorrhagic fever virus (SHFV; a simian arterivirus), a rare mode of virus entry that is shared with other hemorrhagic fever-causing viruses (e.g., Ebola and Lassa viruses). Further, SHFV enters and replicates in human monocytes, indicating full functionality of all of the human cellular proteins required for viral replication. Thus, simian arteriviruses in nature may not require major adaptations to the human host. Given that at least three distinct simian arteriviruses have caused fatal infections in captive macaques after host-switching, and that humans are immunologically naive to this family of viruses, development of serology tests for human surveillance should be a priority.
Insights
Simian hemorrhagic fever virus (SHFV) uses CD163 as an intracellular receptor, similar to Ebola and Lassa viruses. SHFV can infect human cells, suggesting a potential risk for human populations.
Area of Science:
- Virology and Immunology
- Infectious Diseases
- Primate Health
Background:
- Simian arteriviruses are prevalent in African primates.
- These viruses can cause fatal hemorrhagic fevers upon cross-species transmission.
- Previous research has not fully elucidated the entry mechanism of simian hemorrhagic fever virus (SHFV).
Purpose of the Study:
- To identify the cellular receptor for simian hemorrhagic fever virus (SHFV).
- To investigate the potential of SHFV to infect human cells.
- To assess the risk of simian arteriviruses to human health.
Main Methods:
- Investigated the role of CD163 as an intracellular receptor for SHFV.
- Assessed SHFV entry and replication in human monocytes.
- Compared SHFV entry mechanisms with other hemorrhagic fever viruses.
Main Results:
- CD163 was identified as an intracellular receptor for SHFV.
- SHFV demonstrated the ability to enter and replicate within human monocytes.
- The entry mechanism is shared with other dangerous hemorrhagic fever viruses like Ebola and Lassa.
Conclusions:
- Simian arteriviruses may not require significant adaptation to infect humans.
- Human monocytes are fully permissive to SHFV replication.
- Developing serology tests for human surveillance is a critical priority due to potential zoonotic risk.
Related Concept Videos
Viral Recombination
Viral Mutations
Cross-reactivity
Subviral Agents

